Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. Gemici A, et al. Among authors: ozkalemkas f. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34059487
Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: results of a randomized multicenter phase III trial.
Beksac M, Ali R, Ozcelik T, Ozcan M, Ozcebe O, Bayik M, Paydas S, Buyukasik Y, Ilhan O, Ozkalemkas F, Gurman G, Uysal A, Akan H, Soydan EA, Tunali A. Beksac M, et al. Among authors: ozkalemkas f. Leuk Res. 2011 Mar;35(3):340-5. doi: 10.1016/j.leukres.2010.07.005. Epub 2010 Jul 29. Leuk Res. 2011. PMID: 20673585 Clinical Trial.
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S, Cengiz Seval G, Yönal Hindilerden İ, Hindilerden F, Andıç N, Baydar M, Aydın Kaynar L, Toprak SK, Göksoy HS, Balık Aydın B, Demirci U, Can F, Özkocaman V, Gündüz E, Güven ZT, Özkurt ZN, Demircioğlu S, Beksaç M, İnce İ, Yılmaz U, Eroğlu Küçükdiler H, Abishov E, Yavuz B, Ataş Ü, Mutlu YG, Baş V, Özkalemkaş F, Üsküdar Teke H, Gürsoy V, Çelik S, Çiftçiler R, Yağcı M, Topçuoğlu P, Çeneli Ö, Abbasov H, Selim C, Ar MC, Yücel OK, Sadri S, Albayrak C, Demir AM, Güler N, Keklik M, Terzi H, Doğan A, Yegin ZA, Kurt Yüksel M, Sadri S, Yavaşoğlu İ, Beköz HS, Aksu T, Maral S, Erol V, Kaynar L, İlhan O, Bolaman AZ, Sevindik ÖG, Akyay A, Özcan M, Gürman G, Ünal Ş, Yavuz Y, Diz Küçükkaya R, Özsan GH. Civriz Bozdağ S, et al. Among authors: ozkalemkas f. Turk J Haematol. 2022 Feb 23;39(1):43-54. doi: 10.4274/tjh.galenos.2021.2021.0287. Epub 2021 Sep 15. Turk J Haematol. 2022. PMID: 34521187 Free PMC article.
Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E, Kırkızlar HO, Ümit EG, Karaman Gülsaran S, Özkocaman V, Özkalemkaş F, Candar Ö, Elverdi T, Küçükyurt S, Paydaş S, Çeneli Ö, Karakuş S, Maral S, Ekinci Ö, İpek Y, Kis C, Güven ZT, Akdeniz A, Celkan T, Eroğlu Küçükdiler AH, Akgün Çağlıyan G, Özçelik Şengöz C, Karataş A, Bulduk T, Özcan A, Belen Apak FB, Canbolat A, Kartal İ, Ören H, Töret E, Özdemir GN, Bakanay Öztürk ŞM. Gündüz E, et al. Among authors: ozkalemkas f. Turk J Haematol. 2022 Jun 1;39(2):130-135. doi: 10.4274/tjh.galenos.2022.2021.0670. Epub 2022 Feb 18. Turk J Haematol. 2022. PMID: 35176839 Free PMC article.
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
Baysal M, Gürsoy V, Hunutlu FC, Erkan B, Demirci U, Bas V, Gulsaran SK, Pinar IE, Ersal T, Kirkizlar TA, Atli EI, Kirkizlar HO, Ümit EG, Gürkan H, Ozkocaman V, Ozkalemkas F, Demir AM, Ali R. Baysal M, et al. Among authors: ozkalemkas f. Ann Hematol. 2022 May;101(5):1049-1057. doi: 10.1007/s00277-022-04798-8. Epub 2022 Feb 21. Ann Hematol. 2022. PMID: 35190843
Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia.
Yalçın C, Özkalemkaş F, Özkocaman V, Ersal T, Pınar İE, Orhan B, Candar Ö, Çubukçu S, Koca TG, Akyol MN, Ada NG, Özakın C, Kazak E, Akalın H, Ali R. Yalçın C, et al. Among authors: ozkalemkas f. Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022039. doi: 10.4084/MJHID.2022.039. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35615332 Free PMC article.
82 results